Table 2 Comparison of baseline indicators in different therapeutic effect groups
Indicators | Effective group (N = 44) | Ineffective group (N = 48) | Z/χ2 | P |
|---|---|---|---|---|
Sex (male%) | 24 (53.3%) | 27 (56.3%) | 0.080 | 0.778 |
Age (y) | 56 (38, 66) | 60 (51.5, 67.5) | − 1.427 | 0.154 |
Hb (g/L) | 126 (109, 142) | 121 (110, 136) | − 0.628 | 0.530 |
Alb (g/L) | 27.3 (23.4, 30) | 25 (18.7, 30.0) | − 1.772 | 0.076 |
HDL (mmol/L) | 1.2 (1.1, 1.8) | 1.21 (1.0, 1.6) | − 0.594 | 0.552 |
LDL (mmol/L) | 4.2 (3.1, 4.9) | 4.54 (3.2, 6.1) | − 1.061 | 0.289 |
TG (mmol/L) | 2.1 (1.5, 3.2) | 2.5 (1.8, 3.5) | − 1.581 | 0.114 |
CHOL (mmol/L) | 6.3 (5.1, 7.0) | 7.3 (5.5, 8.9) | − 1.757 | 0.079 |
Scr (μmol/L) | 58.4 (48.1, 75.7) | 65.6 (56.4, 76.65) | − 1.403 | 0.161 |
UA (μmol/L) | 377 (284, 452) | 365 (293.5, 412.5) | − 0.511 | 0.609 |
24hpro (g/24 h) | 4.1 (3.4, 5.2) | 4.2 (3.3, 5.1) | − 0.008 | 0.994 |
eGFR (mL/min/1.73m2) | 103.5 (89.9, 114.0) | 98.4 (87.1, 106.7) | − 1.714 | 0.086 |